The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 2006

Conditions
HIV Infections
Interventions
DRUG

Alendronate

DRUG

Calcium carbonate

DRUG

Vitamin D

Trial Locations (28)

10011

Chelsea Clinic, New York

19104

University of Pennsylvania, Philadelphia, Philadelphia

20007

Georgetown University Medical Center, Washington D.C.

27514

Univ of North Carolina, Chapel Hill

37203

Comprehensive Care Clinic, Nashville

43210

Ohio State University, Columbus

46202

Wishard Hosp, Indianapolis

60612

Cook County Hospital Core Center, Chicago

92103

University of California, San Diego, San Diego

94110

San Francisco General Hospital, San Francisco

98104

University of Washington (Seattle), Seattle

35294-2050

University of Alabama-Birmingham, Birmingham

90095-1793

UCLA School of Medicine, Los Angeles

94305-5107

Stanford Univ, Stanford

60611-5012

Northwestern University, Chicago

46202-5250

Indiana Univ Hosp, Indianapolis

Methodist Hosp of Indiana, Indianapolis

55455-0392

Univ of Minnesota, Minneapolis

68198-5130

Nebraska Health System, Omaha

10016-6481

NYU/Bellevue, New York

14642-0001

AIDS Community Health Center, Rochester

Univ of Rochester Med Ctr, Rochester

44106-5083

Case Western Reserve Univ, Cleveland

44109-1998

MetroHealth Medical Center, Cleveland

02906

Rhode Island Hosp, Providence

Stanley Street Treatment and Resource, Providence

The Miriam Hosp, Providence

77555-0435

Univ of Texas, Galveston, Galveston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH